Type 2 Diabetes Flashcards
(38 cards)
What is the HbA1c for pre diabetes
42-47mmol/mol
what are the two diagnostic results for confirmed diabetes
HbA1c of 48 or more
fasting plasma BG of 7 or more
What is 2nd line when there is low CVD risk?
and if these dont work?
pioglitazone
sulphonylurea
SGLT2-i
DPP-4i
What is 2nd line when there is high CVD risk
SGLT2-i
What is the treatment plan for high cvd risk and the patient does not tolerate metformin
SGLT2-i alone
What is HbA1c target if pt is not taking any drugs associated with hypoglycaemia and being managed on lifestyle with/without single drug
48mmol/mol
6.5%
What is HbA1c target if pt is taking a drug associated with hypoglycaemia and being managed on lifestyle with/without single drug
53mmol/mol
7%
What is the HbA1c target for a patient on a single drug
53mmol/mol
7%
What is classed as uncontrolled HbA1c for a patient on a single drug
more than 58mmol/mol
7.5%
Metformin is what type of drug
what is its action
biguanide
Decreases gluconeogenesis and increases peripheral utilisation of glucose
MHRA for metformin
reduced vitamin B12 levels
What are the side effects of metformin
lactic acidosis
GI - N&V, diarrhoea
what increases the risk of lactic acidosis
reduced kidney function
increased alcohol intake
What are examples of DPP-4i
alogliptin
linagliptin
sitagliptin
saxagliptin
vildagliptin
What is the action of DPP-4i
inhibits DPP-4 to increase insulin secretion and reduce glucagon secretion
what is avoided and cautioned in DPP-4i
avoid in ketoacidosis
caution in heart failure
What is a key side effect of DPP-4i
pancreatitis - stop if symptoms occur
What is the action of pioglitazone
reduces peripheral insulin resistance
What is a contraindication for pioglitazone
C/I in history of heart failure
What are the 4 risks with taking pioglitazone
increased risk of bladder cancer
increased risk of bone fractures
increased risk of infection
increased risk of liver toxicity
What are examples of sulphonylureas
Long acting: glibencamide, glimepiride
Short acting: gliclazide, tolbutamide
What is a key side effect of sulphonylureas
HYPOglycaemia
What is avoided for sulphonylureas
avoid prescribing in acute porphyria
avoid in hepatic and renal failure
long acting avoided in elderly
What are examples of SGLT2-i
canagliflozin
dapagliflozin
empagliflozin
ertugliflozin